Carly Fiorina benefited from company using aborted fetal stem cells.
Republican presidential candidate Carly Fiorina benefited from serving on the board of a company using aborted fetal stem cells to the tune of over $83,000 dollars.
Al Jazeera America obtained corporate documents showing that: “Carly Fiorina, a staunch opponent of abortion, made at least $83,000 serving on the board of directors of Merck & Co. at a time when the pharmaceutical company was producing vaccines using fetal stem cell lines derived from aborted fetuses.”
According to Al Jazeera’s program “Inside Story” with Ray Suarez, “She served on Merck’s board from April of 1999 through December of 2000, according to Merck’s SEC filings from the time.” Al Jazeera also reports that “In addition to the $83,000 Fiorina received over her two years on the board, the company’s SEC filings indicate she was to receive an additional $1,200 for each board meeting she attended.”
More recently, in 2010 Fiorina defended the use of aborted fetal stem cells while debating Sen. Barbara Boxer during her failed 2010 Senate bid.
As the Los Angeles Times reported at the time, asked about stem cell research, Fiorina responded that she was comfortable with the use of federal funds for research using adult stem cells and embryos that would have otherwise been destroyed. She went on to clarify that she did not support the creation of embryos specifically for research, however.
It is when embryos are produced for the purposes of destruction, for the purposes of stem cell research that I have a great deal of difficulty.”
Debi Vinnedge, executive director of anti-abortion group Children of God for Life, told “Inside Story” that Fiorina may not have known that Merck’s vaccines utilized stem-cells derived from aborted fetuses at the time of her tenure on the company’s board; however, she conceded that “if she’s stridently pro-life and against Planned Parenthood, she would not be in favor. She would not want to be on the board of a company that was doing that.”
Republican nominee Mitt Romney had similar problems during his failed 2012 bid for the presidency when it was reported that he had profited from investments in a company that disposed of medical waste from abortion clinics.